Titan Biotech Ltd

NSE: BSE: 524717

₹1212.15

(6.53%)

Sat, 14 Feb 2026, 10:25 pm

MTF 5xInvest in Titan Biotech Ltd with 5x Leverage Buy with MTF

Market Cap10.02B

PE Ratio36.82

Dividend0.16

Health Technology

Biotechnology

24.5K

Titan Biotech EV/EBITDA Ratio

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	13.90	11.92	15.97	13.28	8.75	6.04	8.16	13.89	15.35	16.40	19.16	10.56	4.99	5.05	9.99	6.55	17.56	16.18
Price to book ratio	1.34	0.99	1.48	1.42	0.79	0.55	0.79	1.11	1.26	1.56	2	1.16	0.90	2.23	2.51	1.48	3.27	2.27
Price to sales ratio	0.85	0.63	0.83	0.73	0.48	0.29	0.31	0.56	0.59	0.68	0.85	0.57	0.44	1.08	1.75	1.13	2.66	2.23
Price to cash flow ratio	0	5.51	14.07	7.19	8.66	7.03	0	0	7.11	0	0	11.71	9.32	8.73	10.23	7.96	21.85	18.03
Enterprise value	109.21M	88.68M	144.14M	160.42M	121.53M	95.16M	171.98M	300.25M	360.56M	550.74M	744.39M	603.82M	596.14M	1.67B	2.19B	1.66B	4.42B	3.46B
Enterprise value to EBITDA ratio	8.28	6.55	9.39	8.36	5.54	3.63	5.39	7.61	9.31	10.21	10.67	6.76	4.42	3.63	6.92	5.54	12.64	13.28
Debt to equity ratio	0.07	0.06	0.14	0.29	0.12	0.25	0.46	0.38	0.53	0.98	1.06	0.74	0.61	0.23	0.10	0.08	0.06	0.02
Return on equity %	0	8.69	9.53	11.03	10.66	9.29	10.01	9.11	8.42	9.79	10.74	12.23	19.80	56.20	27.98	23.82	20.42	15.01

Titan Biotech Ltd Enterprise Value to EBITDA Ratio

The Titan Biotech Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Titan Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Titan Biotech Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Titan Biotech Ltd (NSE: , BSE: 524717) is currently trading at ₹1212.15, with a market capitalization of ₹10.02B. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Titan Biotech Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Titan Biotech Ltd Enterprise Value to EBITDA Ratio Current Value

The current Titan Biotech Ltd Enterprise Value to EBITDA Ratio stands at 13.28.

The latest Titan Biotech Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Titan Biotech Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Titan Biotech Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

2024: 13.28
2023: 12.64
2022: 5.54
2021: 6.92
2020: 3.63

The recent rise in Titan Biotech Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.

What Titan Biotech Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Titan Biotech Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Titan Biotech Ltd.

Titan Biotech Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Titan Biotech Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Titan Biotech Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Titan Biotech Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800